IP Library Granted Patent US 9,867,908
Granted Patent B2
US 9,867,908 · App. 15/132,116 · Granted Jan 16, 2018

Dialysis catheters with fluoropolymer additives

Inventors: Raymond Lareau (Westford, MA); Benjamin Bell (Shrewsbury, MA); Jeannette Ho (Toronto, CA); J. Paul Santerre (Whitby, CA); Carol Lancette (Fort Ann, NY); Theodore Beyer (Queensbury, NY); William Appling (Granville, NY)
Assignee: ANGIODYNAMICS, INC.
A61L29/06A61L29/041A61L29/14A61L29/18A61M1/3653A61M25/0071A61M2025/0031A61M2025/0073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,867,908
App. No.
15/132,116
Granted
Jan 16, 2018
Kind
B2
Abstract

A vascular access catheter is disclosed that has a catheter shaft with a distal end portion with a distal tip having a sloped face that is positioned at an acute angle from the distal tip relative to a longitudinal axis of the catheter shaft. A first, second, and third lumen extend longitudinally through the catheter shaft. The third lumen is configured for receiving a guidewire and may extend a partial length of the catheter or substantially the entire length of the catheter. The first lumen has an aperture located in the angled edge distal end portion of the catheter next to the distal tip and communicates with the first lumen. The second lumen has an aperture that is positioned in the outer surface of the catheter shaft that is in communication with the second lumen, and is spaced proximally from the first lumen aperture. The catheter includes a fluoropolymer additive with specific compositions and/or purity levels.

Claims (28)

1. A catheter comprising:

a catheter shaft (a) defining first and second shaft lumens and (b) forming a distal portion of the catheter, wherein the distal portion of the catheter includes a distal end portion having a distal tip and at least a portion of the distal end portion is substantially sloped with a sloped face that is angled proximally away from the distal tip and is positioned at an acute angle relative to a longitudinal axis of the catheter shaft; and

wherein the catheter comprises a fluoropolymer comprising polyfluoro oligomeric groups; wherein the fluoropolymer is characterized by a weight average molecular weight (Mw) greater than 13 kDa; and wherein the fluoropolymer comprises a trimer in an amount greater than 0 and less than 5.0 percent by weight of the fluoropolymer, wherein the trimer is formed by a reaction of one equivalent of diisocyanate with two equivalents of a perfluorinated alcohol to form a low molecular weight fluoropolymer component containing no soft segment.

2. The catheter of claim 1 , wherein the polydispersity index of said fluoropolymer is less than or equal to 2.0.

3. The catheter of claim 1 , wherein said fluoropolymer is characterized by a weight average molecular weight (Mw) within the range of 14 kDa to 26 kDa.

4. The catheter of claim 1 , wherein said catheter comprises a polycarbonate-based polyurethane.

5. The catheter of claim 1 , wherein said catheter shaft further comprises about 17 weight percent to about 30 weight percent of a radiopaque material.

6. The catheter of claim 1 , wherein said catheter comprises about 1.4 weight percent to about 2.6 weight percent of said fluoropolymer.

7. The catheter of claim 5 , wherein said radiopaque material comprises barium sulfate.

8. The catheter of claim 1 , wherein said catheter shaft comprises a third shaft lumen configured to selectively receive at least a portion of a guidewire, and wherein at least a portion of the third shaft lumen shares a common wall with at least a portion of the first shaft lumen.

9. The catheter of claim 1 , wherein said catheter shaft has an outer wall thickness within the range of 0.015-0.050 inches.

10. The catheter of claim 1 , further comprising a plurality of extension tubes fluidly connected to the shaft, and wherein said extension tubes comprise a fluoropolymer comprising polyfluoro oligomeric groups characterized by a weight average molecular weight (Mw) greater than 13 kDa.

11. A catheter comprising:

a shaft comprising a first lumen, a second lumen, and a distal tip, each of said first and second lumens separated by a common internal septum and terminating at respective first and second apertures;

and

an apex in the shaft defining a portion of the first lumen distal to the second aperture;

wherein the catheter comprises a fluoropolymer comprising polyfluoro oligomeric groups, said fluoropolymer characterized by a weight average molecular weight (Mw) greater than 13 kDa; wherein the fluoropolymer comprises a trimer in an amount greater than 0 and less than 5.0 percent by weight of the fluoropolymer, wherein the trimer is formed by a reaction of one equivalent of diisocyanate with two equivalents of a perfluorinated alcohol to form a low molecular weight fluoropolymer component containing no soft segment; and

wherein a distance between said apex and a longitudinal axis of said shaft is equal to or greater than a distance between an outer wall defining said second lumen and said longitudinal axis of said shaft.

12. The catheter of claim 11 , wherein an outer wall of said first lumen is characterized by an inner angle opposite said apex, said inner angle being between approximately 45 degrees and 135 degrees.

13. The catheter of claim 12 , wherein said inner angle is equal to or greater than about 90 degrees.

14. The catheter of claim 11 , further comprising a guidewire lumen.

15. The catheter of claim 11 , wherein at least one of said apex and said distal tip is configured to abut a wall of a blood vessel wall when said shaft is inserted into said blood vessel.

16. The catheter of claim 11 , wherein the polydispersity index of said fluoropolymer is less than or equal to 2.0.

17. The catheter of claim 11 , wherein said fluoropolymer is characterized by a weight average molecular weight (Mw) within the range of 14 kDa to 26 kDa.

18. The catheter of claim 11 , wherein said catheter comprises a polycarbonate-based polyurethane.

19. The catheter of claim 11 , wherein said catheter further comprises about 20 weight percent to about 30 weight percent of a radiopaque material.

20. The catheter of claim 11 , wherein said catheter comprises about 1.5 weight percent to about 2.5 weight percent of said fluoropolymer.

21. The catheter of claim 11 , further comprising a plurality of extension tubes fluidly connected to the shaft, and wherein said extension tubes comprise a fluoropolymer comprising polyfluoro oligomeric groups characterized by a weight average molecule weight (Mw) greater than 13 kDa.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2023
From: LAREAU, RAYMOND; BELL, BENJAMIN
To: ANGIODYNAMICS, INC.
Reel/Frame 063579/0347 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2019
From: INTERFACE BIOLOGICS, INC.
To: EVONIK CANADA INC.
Reel/Frame 050683/0425 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2019
From: SANTERRE, J. PAUL; HO, JEANNETTE
To: INTERFACE BIOLOGICS INC.
Reel/Frame 048560/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2017
From: LAREAU, RAYMOND; BELL, BENJAMIN
To: ANGIODYNAMICS, INC.
Reel/Frame 041557/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2017
From: LAREAU, RAYMOND; BELL, BENJAMIN
To: ANGIODYNAMICS, INC.
Reel/Frame 041714/0922 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
Continuity (8)
Continuation 14220572 · Mar 20, 2014
Continuation In Part 14100671 · Dec 9, 2013
Continuation 13950592 · Jul 25, 2013
Continuation In Part 14151267 · Jan 9, 2014
Continuation 12392220 · Feb 25, 2009
Division 11557369 · Nov 7, 2006
Provisional Application 61790821 · Mar 15, 2013
Related Publication 20160228616A1 · Aug 11, 2016